Back
Journey Medical Vs. 4D Molecular Therapeutics Industry Stock Comparison
Sell
41
DERM
Journey Medical
Last Price:
5.15
Seasonality Move:
24.9%
Sell
22
FDMT
4D Molecular Therapeutics
Last Price:
13.50
Seasonality Move:
44.72%
Sell
41
Journey Medical (DERM)
is a Sell
Is Journey Medical a Buy, Sell or Hold?
- The current Journey Medical [DERM] share price is $5.17. The Score for DERM is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- DERM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics a Buy, Sell or Hold?
- The current 4D Molecular Therapeutics [FDMT] share price is $13.50. The Score for FDMT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- FDMT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DERM Stock Price Chart
What is Journey Medical's stock price today?
-
The Journey Medical share price today is $5.17
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DERM is experiencing slight selling pressure.
FDMT Stock Price Chart
What is 4D Molecular Therapeutics's stock price today?
-
The 4D Molecular Therapeutics share price today is $13.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing selling pressure, which indicates risk of future bearish movement.
DERM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 54.88 | Buy |
| Chaikin Money Flow: | -5256 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.58 - 5.16) | Buy |
| Bollinger Bands (100): | (4 - 5.52) | Buy |
FDMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 35.8 | Sell |
| Chaikin Money Flow: | -1845577 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.61 - 16.03) | Sell |
| Bollinger Bands (100): | (15.82 - 24.86) | Sell |
DERM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.07 | Buy |
| 20-day SMA: | 4.96 | Buy |
| 50-day SMA: | 5.09 | Buy |
| 200-day SMA: | 4.71 | Buy |
| 8-day EMA: | 5.09 | Buy |
| 20-day EMA: | 5 | Buy |
| 50-day EMA: | 4.96 | Buy |
| 200-day EMA: | 4.46 | Buy |
FDMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.79 | Sell |
| 20-day SMA: | 15.45 | Sell |
| 50-day SMA: | 16.64 | Sell |
| 200-day SMA: | 22.26 | Sell |
| 8-day EMA: | 15.53 | Sell |
| 20-day EMA: | 15.61 | Sell |
| 50-day EMA: | 16.93 | Sell |
| 200-day EMA: | 20.05 | Sell |
Journey Medical Earnings Growth & DERM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.23 per share, a decrease this year of $0.24 per share, and a decrease next year of $0.31 per share.
Journey Medical Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
4D Molecular Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||